Gendedrive inks second distribution agreement with Sysmex

Molecular diagnostics business Genedrive announced on Tuesday that it had signed a distribution agreement with Japanese health care firm Sysmex Asia Pacific for its HCV ID kit and its Genedrive platform in the Asia Pacific region.

The agreement, the second between the two firms, followed the same structure as the previous, with Genedrive retaining responsibility for product development, quality management and manufacturing, and Sysmex being in charge of sales, marketing, customer support and distribution activities across the region.

Both companies would work together to secure regulatory approvals across individual territories within the region.

David Budd, chief executive of Genedrive, said, "This agreement provides access to another important and very relevant global region for Genedrive encompassing countries with a high HCV burden."

Frank Buescher, president and chief executive of Sysmex Asia Pacific, added, "We are excited about this collaboration opportunity with Genedrive and incorporating their HCV assay in our unique offering for Liver Disease management in the APAC region."

As of 0830 GMT, shares had gained 2.43% to 36.87p.